Adiponectin protects Leydig cells against proinflammatory cytokines by suppressing the nuclear factor-κB signaling pathway

FEBS Journal

Volumn 280, Issue 16, 2013, Pages 3920-3927

  Wu, Ling ^a   Xu, Bufang ^a   Fan, Weimin ^a   Zhu, Xiaobin ^a   Wang, Guangyan ^a   Zhang, Aijun ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

adiponectin; AMP activated protein kinase; Leydig cells; nuclear factor B

Indexed keywords

ADIPONECTIN RECEPTOR 1; ADIPONECTIN RECEPTOR 2; CYTOKINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; 3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; ADIPONECTIN; ADIPONECTIN RECEPTOR; ADIPONECTIN RECEPTOR 1, MOUSE; ADIPONECTIN RECEPTOR 2, MOUSE; ADIPOQ PROTEIN, MOUSE; CYCLOOXYGENASE 2; INDUCIBLE NITRIC OXIDE SYNTHASE; NOS2 PROTEIN, MOUSE; PHOSPHOPROTEIN; PTGS2 PROTEIN, MOUSE; STEROIDOGENIC ACUTE REGULATORY PROTEIN;

ANIMAL CELL; ANIMAL CELL CULTURE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ASSAY; CELL PROTECTION; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; INTRACELLULAR SIGNALING; LEYDIG CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; RECEPTOR DOWN REGULATION; AMP-ACTIVATED PROTEIN KINASE; ANIMAL; C57BL MOUSE; CELL LINE; CHEMISTRY; DOWN REGULATION; DRUG ANTAGONISM; DRUG POTENTIATION; GENE SILENCING; GENETICS; IMMUNOLOGY; METABOLISM; NUCLEAR FACTOR-ΚB; PHOSPHORYLATION; PROTEIN PROCESSING; SIGNAL TRANSDUCTION; UPREGULATION;

ADIPONECTIN; AMP-ACTIVATED PROTEIN KINASE; LEYDIG CELLS; NUCLEAR FACTOR-ΚB;

3-HYDROXYSTEROID DEHYDROGENASES; ADIPONECTIN; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CELL LINE; CYCLOOXYGENASE 2; CYTOKINES; DOWN-REGULATION; GENE SILENCING; LEYDIG CELLS; MALE; MICE; MICE, INBRED C57BL; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTORS, ADIPONECTIN; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84885914511     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/febs.12391     Document Type: Article

References (31)

1. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, &, Tobe K, (2006) Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 116, 1784-1792.
2. Maeda N, Shimomura I, Kishida K, Nishizawa H, Matsuda M, Nagaretani H, Furuyama N, Kondo H, Takahashi M, Arita Y, et al,. (2002) Diet-induced insulin resistance in mice lacking adiponectin/ACPR30. Nat Med 8, 731-737.
3. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, et al,. (2002) Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8, 1288-1295.
4. Haluzik M, (2005) Adiponectin and its potential in the treatment of obesity, diabetes and insulin resistance. Curr Opin Investig Drugs 10, 988-993.
5. Ohashi K, Kihara S, Ouchi N, Kumada M, Fujita K, Hiuge A, Hibuse T, Ryo M, Nishizawa H, Maeda N, et al,. (2006) Adiponectin replenishment ameliorates obesity-related hypertension. Hypertension 6, 1108-1116.
6. Xu A, Wang Y, Keshaw H, Xu LY, Lam KS, &, Cooper GJ, (2003) The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J Clin Invest 112, 91-100.
7. Awazawa M, Ueki K, Inabe K, Yamauchi T, Kaneko K, Okazaki Y, Bardeesy N, Ohnishi S, Nagai R, &, Kadowaki T, (2009) Adiponectin suppresses hepatic SREBP1c expression in an AdipoR1/LKB1/AMPK dependent pathway. Biochem Biophys Res Commun 382, 51-56.
8. Daimon M, Oizumi T, Saitoh T, Kameda W, Hirata A, Yamaguchi H, Ohnuma H, Igarashi M, Tominaga M, &, Kato T, (2003) Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese population: the Funagata study. Diabetes Care 26, 2015-2020.
9. Kobayashi H, Ouchi N, Kihara S, Walsh K, Kumada M, Abe Y, Funahashi T, &, Matsuzawa Y, (2004) Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circ Res 94, 27-31.
10. Makino N, Sugano M, Satoh S, Oyama J, &, Maeda T, (2006) Peroxisome proliferator-activated receptor-gamma ligands attenuate brain natriuretic peptide production and affect remodeling in cardiac fibroblasts in reoxygenation after hypoxia. Cell Biochem Biophys 44, 65-71.
11. Ramanjaneya M, Conner AC, Brown JE, Chen J, Digby JE, Barber TM, Lehnert H, &, Randeva HS, (2011) Adiponectin stimulates steroidogenic acute regulatory (StAR) protein expression and cortisol production in human adrenocortical cells: role of AMPK and MAPK kinase pathways. Biochim Biophys Acta 1813, 802-809.
12. Steyn FJ, Boehme F, Vargas E, Wang K, Parkington HC, Rao JR, &, Chen C, (2009) Adiponectin regulates growth hormone secretion via adiponectin receptor mediated Ca(2+) signalling in rat somatotrophs in vitro. J Neuroendocrinol 21, 698-704.
13. Gao L, Zhang Y, Cui Y, Jiang Y, Wang X, &, Liu J, (2012) Association of the T45G and G276T polymorphisms in the adiponectin gene with PCOS: a meta- analysis. Gynecol Endocrinol 28, 106-110.
14. Hong CY, Park JH, Ahn RS, Im SY, Choi HS, Soh J, Mellon SH, &, Lee K, (2004) Molecular mechanism of suppression of testicular steroidogenesis by proinflammatory cytokine tumor necrosis factor alpha. Mol Cell Biol 24, 2593-2604.
15. Wu L, Zhang A, Sun Y, Zhu X, Fan W, Lu X, Yang Q, &, Feng Y, (2012) Sirt1 exerts anti-inflammatory effects and promotes steroidogenesis in Leydig cells. Fertil Steril 98, 194-199.
16. Caminos JE, Nogueiras R, Gaytán F, Pineda R, González CR, Barreiro ML, Castaño JP, Malagõn MM, Pinilla L, Toppari J, et al,. (2008) Novel expression and direct effects of adiponectin in the rat testis. Endocrinology 149, 3390-3402.
17. Ocõn-Grove OM, Krzysik-Walker SM, Maddineni SR, Hendricks GL 3rd, &, Ramachandran R, (2008) Adiponectin and its receptors are expressed in the chicken testis: influence of sexual maturation on testicular ADIPOR1 and ADIPOR2 mRNA abundance. Reproduction 136, 627-638.
18. Bonizzi G, &, Karin M, (2004) The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol 25, 280-288.
19. Chen LF, Williams SA, Mu Y, Nakano H, Duerr JM, Buckbinder L, &, Greene WC, (2005) NF-kappaB Rel A phosphorylation regulates RelA acetylation. Mol Cell Biol 25, 7966-7975.
20. Shibata S, Tada Y, Asano Y, Hau CS, Kato T, Saeki H, Yamauchi T, Kubota N, Kadowaki T, &, Sato S, (2012) Adiponectin regulates cutaneous wound healing by promoting keratinocyte proliferation and migration via the ERK signaling pathway. J Immunol 189, 3231-3241.
21. Nigro E, Scudiero O, Sarnataro D, Mazzarella G, Sofia M, Bianco A, &, Daniele A, (2013) Adiponectin affects lung epithelial A549 cell viability counteracting TNFα and IL-1β toxicity through AdipoR1. Int J Biochem Cell Biol 45, 1145-1153.
22. Nelson LE, Valentine RJ, Cacicedo JM, Gauthier MS, Ido Y, &, Ruderman NB, (2012) A novel inverse relationship between metformin-triggered AMPK-SIRT1 signaling and p53 protein abundance in high glucose-exposed HepG2 cells. Am J Physiol Cell Physiol 303, C4-C13.
23. Rodriguez-Pacheco F, Martinez-Fuentes AJ, Tovar S, Pinilla L, Tena-Sempere M, Dieguez C, Castaño JP, &, Malagon MM, (2007) Regulation of pituitary cell function by adiponectin. Endocrinology 148, 401-410.
24. Kos K, Harte AL, Da Silva NF, Tonchev A, Chaldakov G, James S, Snead DR, Hoggart B, O'Hare JP, McTernan PG, et al,. (2007) Adiponectin and resistin in human cerebrospinal fluid and expression of adiponectin receptors in the human hypothalamus. J Clin Endocrinol Metab 92, 1129-1136.
25. Holland WL, Miller RA, Wang ZV, Sun K, Barth BM, Bui HH, Davis KE, Bikman BT, Halberg N, Rutkowski JM, et al,. (2011) Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. Nat Med 17, 55-63.
26. Lira FS, Rosa JC, Pimentel GD, Seelaender M, Damaso AR, &, Oyama LM, (2012) do Nascimento CO. Both adiponectin and interleukin-10 inhibit LPS-induced activation of the NF-κb pathway in 3T3-L1 adipocytes. Cytokine 57, 98-106.
27. Mealy K, Robinson B, Millette CF, Majzoub J, &, Wilmore DW, (1990) The testicular effects of tumor necrosis factor. Ann Surg 211, 470-475.
28. Van der Poll T, Romijn JA, Endert E, &, Sauerwein HP, (1993) Sauerwein. Effects of tumor necrosis factor on the hypothalamic-pituitary- testicular axis in healthy men. Metabolism 42, 303-307.
29. Hutson JC, (2006) Physiologic interactions between macrophages and Leydig cells. Exp Biol Med 231, 1-7.
30. Ferraz-de-Souza B, Lin L, &, Achermann JC, (2011) Steroidogenic factor (SF-1, NR5A1) and human disease. Mol Cell Endocrinol 10, 198-205.
31. El-Khairi R, Martinez-Aguayo A, Ferraz-de-Souza B, Lin L, &, Achermann JC, (2011) Role of DAX-1 (NR0B1) and steroidogenic factor-1 (NR5A1) in human adrenal function. Endocr Dev 20, 38-46.